Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Burkitt Lymphoma 1

Interventions

Filgrastim 11Cyclophosphamide 11Rituximab 10fludarabine phosphate 9Mycophenolic Acid 9Cyclosporine 9Antilymphocyte Serum 9Radiotherapy 7Peripheral Blood Stem Cell Transplantation 7Whole-Body Irradiation 6Cord Blood Stem Cell Transplantation 6Polymerase Chain Reaction 5Methotrexate 5Flow Cytometry 5Busulfan 5Tacrolimus 4Methylprednisolone 4Etoposide 4Amplified Fragment Length Polymorphism Analysis 4tanespimycin 3sargramostim 3Melphalan 3Lenalidomide 3Granulocyte Colony-Stimulating Factor 3Gene Expression Profiling 3Bortezomib 3thymoglobulin 2plerixafor 2aldesleukin 2Stem Cell Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Lymphoma, Large-Cell, Immunoblastic × CK0238273 × Clear all
NCT00101244 2013-01-14

SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 1 Terminated
31 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡